Pfizer Can't Shake Securities Action Over Celebrex Risks

Law360, New York (March 29, 2013, 5:23 PM ET) -- A New York federal judge on Thursday trimmed a long-running securities class action accusing Pfizer Inc. of concealing serious health risks associated with blockbuster painkillers Celebrex and Bextra, but ruled the bulk of the plaintiff's allegations were strong enough to advance.

U.S. District Judge Laura Taylor Swain whittled away some claims that were based on various news reports about deaths allegedly linked to the drugs because the causal connection was refuted by health officials. She also tossed allegations related to statements made by certain company officials...
To view the full article, register now.




Case Information

Case Title

In Re: Pfizer Securities Litigation

Case Number



New York Southern

Nature of Suit



Laura Taylor Swain

Date Filed

December 14, 2004

Law Firms


Government Agencies

Dewey Verdict Watch

Follow our exclusive coverage of the trial of the year:

Click here for the latest